Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | TAS2R46 | P59540 | 6/20 | 0.33 |
| ▸ | TAS2R31 | P59538 | 2/20 | 0.33 |
| ▸ | TAS2R10 | Q9NYW0 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4740720 | 1.00 | LMNA (0.55) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL10831405 | 0.86 | LMNA (0.51) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL25622935 | 0.80 | LMNA (0.46) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL3930807 | 0.80 | LMNA (0.53) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL2431486 | 0.79 | LMNA (0.51) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL31601392 | 0.79 | LMNA (0.51) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL15450107 | 0.79 | LMNA (0.66) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL937050 | 0.79 | LMNA (0.60) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL12909964 | 0.79 | LMNA (0.66) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL1783157 | 0.79 | LMNA (0.66) | LMNATSHRALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7592463-B2 | An imidazolidinone compounds is used in reaction as catalyst to lower the energy level of the lowest unoccupied molecular orbital | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592463-B2 | An imidazolidinone compounds is used in reaction as catalyst to lower the energy level of the lowest unoccupied molecular orbital | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-09-22 | — | — | US | disclosed |
| EP-1461320-B1 | ENANTIOSELECTIVE TRANSFORMATION OF ALFA,BETA-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2008-04-09 | — | — | EP | disclosed |
| US-20030220507-A1 | Enantioselective transformation of alpha,beta-unsaturated ketones using chiral organic catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2003-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220507-A1 | Enantioselective transformation of alpha,beta-unsaturated ketones using chiral organic catalysts | HACL2, EBP, MED1 | LMNA 1897/4885TSHR 4272/4885ALDH1A1 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.